Breaking News Instant updates and real-time market news.

VRX

Valeant

$26.86

0.06 (0.22%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55

FDA PDUFA Date for Valeant Pharmaceuticals IDP-118 is June 18, 2017

  • 18

    Jun

  • 27

    Aug

VRX Valeant
$26.86

0.06 (0.22%)

06/05/18
HCWC
06/05/18
NO CHANGE
Target $20
HCWC
Neutral
Valeant gradually obtaining more financial flexibility, says H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju says Valeant Pharmaceuticals is gradually obtaining more financial flexibility, as the shorter-term debt tranches have been considerably reduced. The company last week announced that it had entered into a fourth amended and restated credit and guaranty agreement effectuating a full refinancing of its secured revolving and term loan credit facilities, Selvaraju tells investors in a research note. He reiterates a Neutral rating on Valeant with a $20 price target, however, awaiting evidence of the company returning to long-term sustainable growth.
06/06/18
LEHM
06/06/18
UPGRADE
Target $29
LEHM
Overweight
Valeant upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Valeant Pharmaceuticals to Overweight from Equal Weight and raised his price target for the shares to $29 from $20. The drugmaker closed yesterday up $1.59 to $23.59. Valeant's business has hit an inflection point with its existing business stabilizing, which offers a foundation for the company to enjoy growth driven by upcoming product launches, Tsao tells investors in a research note. While none of the launches are likely to be "blockbusters," with base business performing well and impact of loss-of-exclusivities lessening after this year, the "threshold for success has come down meaningfully," Tsao contends.
06/06/18
06/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Valeant (VRX) upgraded to Overweight from Equal Weight at Barclays analyst Douglas Tsao saying Valeant's business has hit an inflection point with its existing business stabilizing, which offers a foundation for the company to enjoy growth driven by upcoming product launches. 2. G-III Apparel (GIII) upgraded to Equal Weight from Underweight at Barclays with analyst Chethan Mallela saying he sees improving visibility following the company's Q1 results. 3. Cigna (CI) upgraded to Buy from Neutral at Goldman Sachs. 4. Shaw Communications (SJR) upgraded to Outperformer from Neutral at CIBC. 5. International Paper (IP) upgraded to Outperform from Sector Perform at RBC Capital with analyst Paul Quinn citing the announcement that International Paper will not make an offer for Smurfit Kappa. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/14/18
HCWC
06/14/18
NO CHANGE
HCWC
Buy
Palatin weakness 'undeserved' following Addyi relaunch, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis attributes recent weakness in shares of Palatin (PTN) to the relaunch of Addyi by Sprout, and its first-to-market status, following reacquisition of the drug from Valeant (VRX). However, he sees the weakness as undeserved, as he continues to believe that Addyi is an inferior drug with a "sketchy history," Pantginis tells investors. Addyi's "one singular advantage," education and visibility for hypoactive sexual desire disorder, should help the market for Palatin's bremelanotide, which has a "potentially market leading profile," said the analyst, who keeps a Buy rating on Palatin shares.

TODAY'S FREE FLY STORIES

AXP

American Express

$102.93

1.79 (1.77%)

16:08
07/18/18
07/18
16:08
07/18/18
16:08
Earnings
American Express reports Q2 EPS $1.84, consensus $1.82 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

KMI

Kinder Morgan

$17.80

0.11 (0.62%)

16:08
07/18/18
07/18
16:08
07/18/18
16:08
Earnings
Kinder Morgan reports Q2 adjusted EPS 21c, consensus 19c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GBNK

Guaranty Bancorp

$30.70

0.25 (0.82%)

16:08
07/18/18
07/18
16:08
07/18/18
16:08
Earnings
Breaking Earnings news story on Guaranty Bancorp »

Guaranty Bancorp reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.27

-0.64 (-0.65%)

16:08
07/18/18
07/18
16:08
07/18/18
16:08
Hot Stocks
PTC advances transition to subscription business model »

PTC announced a milestone…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GBX

Greenbrier

$55.10

0.25 (0.46%)

16:08
07/18/18
07/18
16:08
07/18/18
16:08
Initiation
Greenbrier initiated  »

Greenbrier initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFPI

Universal Forest

$38.35

-0.205 (-0.53%)

16:07
07/18/18
07/18
16:07
07/18/18
16:07
Earnings
Universal Forest reports Q2 EPS 71c, consensus 73c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLG

SL Green Realty

$100.51

0.29 (0.29%)

16:07
07/18/18
07/18
16:07
07/18/18
16:07
Earnings
SL Green Realty reports Q2 FFO $1.69, consensus $1.68 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ICFI

ICF International

$72.50

-0.5 (-0.68%)

16:07
07/18/18
07/18
16:07
07/18/18
16:07
Hot Stocks
ICF International awarded infrastructure contract by LA County Public Works »

ICF has been selected by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

TCBI

Texas Capital

$94.00

2.2 (2.40%)

16:06
07/18/18
07/18
16:06
07/18/18
16:06
Earnings
Texas Capital reports Q2 EPS $1.38, consensus $1.39 »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

IBM

IBM

$144.32

0.86 (0.60%)

16:06
07/18/18
07/18
16:06
07/18/18
16:06
Earnings
IBM reports Q2 cognitive solutions revenue $4.6B, flat y/y »

Reports Q2 global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

IBM

IBM

$144.32

0.86 (0.60%)

16:05
07/18/18
07/18
16:05
07/18/18
16:05
Hot Stocks
IBM says strategic imperatives revenue was $39B over last 12 months »

Strategic imperatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

PTC

PTC

$98.13

-0.78 (-0.79%)

16:05
07/18/18
07/18
16:05
07/18/18
16:05
Earnings
PTC sees FY18 EPS $1.41-$1.46, consensus $1.39 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

DWCH

Datawatch

$11.30

-0.3 (-2.59%)

16:04
07/18/18
07/18
16:04
07/18/18
16:04
Earnings
Datawatch reports Q3 EPS 7c, consensus (5c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Aug

  • 16

    Aug

PFBC

Preferred Bank

$63.93

0.18 (0.28%)

16:04
07/18/18
07/18
16:04
07/18/18
16:04
Earnings
Preferred Bank reports Q2 EPS $1.14, consensus $1.09 »

Q2 net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Sep

  • 07

    Nov

IBM

IBM

$144.39

0.93 (0.65%)

16:04
07/18/18
07/18
16:04
07/18/18
16:04
Earnings
IBM backs FY18 adjusted EPS view of 'at least' $13.80, consensus $13.78 »

Operating diluted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

ORRF

Orrstown Financial

$25.60

-0.5 (-1.92%)

16:04
07/18/18
07/18
16:04
07/18/18
16:04
Earnings
Orrstown Financial reports Q2 EPS 48c, consensus 39c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.28

-0.63 (-0.64%)

16:04
07/18/18
07/18
16:04
07/18/18
16:04
Earnings
PTC sees Q3 EPS 41c-46c, consensus 41c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

IBM

IBM

$144.32

0.86 (0.60%)

16:03
07/18/18
07/18
16:03
07/18/18
16:03
Earnings
IBM reports Q2 operating EPS $3.08, consensus $3.04 »

Reports Q2 revenue $20B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

CP

Canadian Pacific

$189.21

3.205 (1.72%)

16:03
07/18/18
07/18
16:03
07/18/18
16:03
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PTC

PTC

$98.28

-0.63 (-0.64%)

16:03
07/18/18
07/18
16:03
07/18/18
16:03
Hot Stocks
PTC reports Q3 deferred revenue $1.21B, up 33% »

Third quarter license and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CP

Canadian Pacific

$189.21

3.205 (1.72%)

16:03
07/18/18
07/18
16:03
07/18/18
16:03
Hot Stocks
Canadian Pacific CEO says 'well positioned for a strong second half' »

"Overall, it was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CP

Canadian Pacific

$189.16

3.155 (1.70%)

16:02
07/18/18
07/18
16:02
07/18/18
16:02
Hot Stocks
Canadian Pacific reports Q2 operating ratio 64.2% »

An increase of 140 basis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PTC

PTC

$98.33

-0.58 (-0.59%)

16:02
07/18/18
07/18
16:02
07/18/18
16:02
Earnings
PTC reports Q3 adjusted EPS 36c, consensus 32c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CP

Canadian Pacific

$189.17

3.165 (1.70%)

16:01
07/18/18
07/18
16:01
07/18/18
16:01
Earnings
Canadian Pacific reports Q2 adjusted EPS C$3.16, consensus C$3.08 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CVCY

Central Valley Community

$21.15

-0.05 (-0.24%)

16:01
07/18/18
07/18
16:01
07/18/18
16:01
Earnings
Central Valley Community reports Q2 EPS 36c, consensus 34c »

"The second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.